Drug Trial Radar · NCT01541553
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Last checked: Nov 20, 2026Latest source record: Mar 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
367
Actual
Start
Mar 2012
Primary completion
Jul 2013
Study completion Jul 2013
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to compare the rate of complete clearance of actinic keratosis (AK) using sequential cryotherapy and field treatment with PEP005 Gel compared to cryotherapy alone.
Conditions
- Actinic Keratosis
Interventions
CryotherapyProcedure
Cryotherapy of all visible AKs (4-8 lesions, "baseline lesions") in the selected treatment area
VehicleDrug
Field treatment with vehicle gel once daily for 3 consecutive days.
Ingenol metabuteDrug
Field treatment with vehicle gel once daily for 3 consecutive days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Clearance of AKs at Week 11Time frame: 11 weeks
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Center for Dermatology Clinical Research
Fremont, California
Dermatology Specialists, Inc.
Oceanside, California
Skin Surgery Medical Group, Inc.
San Diego, California
University Clinical Trials, Inc.
San Diego, California
Colorado Medical Research Center, Inc.
Denver, Colorado
About Skin Dermatology and DermSurgery, PC
Englewood, Colorado
The Center for Clincial and Cosmetic Research
Aventura, Florida
Study Protocol, Inc.
Boynton Beach, Florida
North Florida Dermatology Associates, PA
Jacksonville, Florida
University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare
Tampa, Florida
MedaPhase
Newnan, Georgia
Gwinnett Clinical Research Center, Inc.
Snellville, Georgia
Altman Dermatology Associates
Arlington Heights, Illinois
Laser & Skin Surgery Center of Indiana
Carmel, Indiana
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
Great Lakes Research Center
Bay City, Michigan
Henry Ford Medical Centre - New Center One, Department of Dermatology
Detroit, Michigan
Grekin Skin Institute
Warren, Michigan
Minnesota Clinical Study Center
Fridley, Minnesota
Academic Dermatology Associates
Albuquerque, New Mexico
Mount Sinai School of Medicine
New York, New York
Skin Search of Rochester, Inc.
Rochester, New York
Long Island Skin Cancer and Dermatologic Surgery
Smithtown, New York
Oregon Medical Research Center, PC
Portland, Oregon
Oregon Health & Science University, Dept. of Dermatology
Portland, Oregon
Philadelphia Institute of Dermatology
Fort Washington, Pennsylvania
Dermatology Research Associates, Inc.
Nashville, Tennessee
Arlington Research Center, Inc.
Arlington, Texas
Suzanne Bruce and Associates, P.A.
Houston, Texas
Dermatology Clinical Research Center of San Antonio
San Antonio, Texas
Center for Clinical Studies
Webster, Texas
Dermatology Research Center, Inc.
Salt Lake City, Utah
The Education & Research Foundation, Inc.
Lynchburg, Virginia
Virginia Clinical Research, Inc.
Norfolk, Virginia
Premier Clinical Research
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.